Regina
Regina Bruggisser, Winterthur CH
Patent application number | Description | Published |
---|---|---|
20140163485 | WOUND DRESSING - A wound dressing for wound treatment in a moist or wet milieu includes a fibrous non woven fabric-based suction-/rinsing body, a superabsorbent material distributed in the suction-/rinsing body and including negative groups, a saline aqueous solution including an antimicrobially acting substance which is cationic at pH values of 4-7.5 of the moist or wet milieu, wherein the antimicrobially acting substance is attracted and retained by the negative groups of the superabsorbent material, and is supplied to the suction-/rinsing body by the manufacturer, and a cover forming outer visible sides of the wound dressing, wherein an atraumatically acting coating is applied in some regions and in a structured manner on one of the outer visible sides which faces toward the wound, with a degree of coverage of at most 70%. | 06-12-2014 |
Regina Danielewicz, Wroclaw PL
Patent application number | Description | Published |
---|---|---|
20140205839 | PURE ALBUMIN AND ITS METHOD OF PREPARATION AND DETECTION - The subject of the present invention is a pure monomeric bovine serum albumin, a method of producing it characterised by the use column chromatography in resin and a method of identifying it using dynamic light scattering. | 07-24-2014 |
Regina Desanctis-Smith, Scottsdale, AZ US
Patent application number | Description | Published |
---|---|---|
20080215181 | METHOD AND SYSTEM FOR PERFORMING INVASIVE MEDICAL PROCEDURES USING A SURGICAL ROBOT - A method and system for performing invasive procedures includes a surgical robot which is controlled by a guidance system that uses time of flight calculations from RF transmitters embedded in the robot, surgical instrument, and patient anatomy. Sensors around the room detect RF transmissions emitted by the RF transmitters and drive the robot according to a preprogrammed trajectory entered into the guidance system. | 09-04-2008 |
20130123799 | METHOD AND SYSTEM FOR PERFORMING INVASIVE MEDICAL PROCEDURES USING A SURGICAL ROBOT - A method and system for performing invasive procedures includes a surgical robot which is controlled by a guidance system that uses time of flight calculations from RF transmitters embedded in the robot, surgical instrument, and patient anatomy. Sensors around the room detect RF transmissions emitted by the RF transmitters and drive the robot according to a preprogrammed trajectory entered into the guidance system. | 05-16-2013 |
Regina Feederle, Heidelberg DE
Patent application number | Description | Published |
---|---|---|
20110059133 | EX VIVO METHOD FOR PRODUCING A PREPARATION CONTAINING CD4+ T CELLS SPECIFIC FOR EBV STRUCTURAL ANTIGENS - The present invention discloses an ex vivo method for producing a preparation containing CD4+ T cells specific for EBV structural antigens for use in the prophylaxis and treatment of patients with a reduced T cell activity in order to prevent or treat growth of EBV infected B cells. | 03-10-2011 |
20140322255 | SECOND GENERATION VIRUS-LIKE PARTICLES (VLP) FROM EPSTEIN-BARR VIRUSES FOR VACCINATION PURPOSES - The present invention relates to an Epstein-Barr virus-like particle (EB-VLP) substantially free of Epstein-Barr Virus (EBV) DNA. The present invention also relates to a polynucleotide comprising an EBV genome a) lacking at least one expressible gene selected from the group consisting of the BFLF1 gene, the BBRF gene, the BGRF1 gene, the BDRF1 gene, the BALF3 gene, the BFRF1A gene, and the BFRF1 gene, and b) producing the EB-VLP of the invention in a suitable host cell. The present invention further relates to a vector and a host cell comprising the polynucleotide of the invention as well to a method of manufacturing said EB-VLPs, a method of manufacturing a vaccine thereof, a vaccine and a composition comprising said EB-VLPs. | 10-30-2014 |
Regina Fischer, Karlsruhe DE
Patent application number | Description | Published |
---|---|---|
20090326278 | Modified carbon nanoparticles, method for the production thereof and use thereof - The present invention relates to novel carbon nanoparticles, especially to carbon nanoparticles which comprise or consist of carbon nanotubes and have been modified by means of acyl groups, to a novel process with which these modified carbon nanoparticles, especially carbon nanoparticles comprising or consisting of carbon nanotubes, are obtainable, and to the use of the modified carbon nanoparticles, especially carbon nanoparticles comprising or consisting of carbon nanotubes. | 12-31-2009 |
20110112287 | CARBON NANOPARTICLES, WHICH ARE COVALENTLY BOUND VIA A BRIDGE MOLECULE TO A TARGET MOLECULE, AND A METHOD FOR THE PRODUCTION THEREOF - A method for covalently binding target molecules to carbon nanoparticles via at least one bridge molecule includes converting carbon nanoparticles to acyl carbon nanoparticles using a carbonyl compound of the at least one bridge molecule in the presence of a Lewis acid under Friedel-Crafts conditionsm, where the acyl carbon nanoparticles include a nucleofuge in the omega position. The target molecule is covalently bound to the acyl carbon nanoparticles via nucleophilic substitution of the nucleofuge in the omega position. | 05-12-2011 |
Regina Gil Garcia US
Patent application number | Description | Published |
---|---|---|
20130277461 | Method And Electro-Fluidic Device To Produce Emulsions And Particle Suspensions - The invention refers to a method, and to a device to produce emulsions and particle suspensions by using electro-hydrodinamic forces and microfluidics This combined use allow the production of droplets with mean diameters which may be either smaller than those obtained in conventional microfluidic devices or larger than those obtained by electrospray, bridging the gap between the two methods acting independently. | 10-24-2013 |
Regina Goralczyc, Grenzach-Wyhlen DE
Patent application number | Description | Published |
---|---|---|
20090155381 | Method of treatment or prevention of age-related macular degeneration - A method of treatment and/or prevention of age-related macular degeneration (AMD) wherein, in a first step, the need for treatment or susceptibility to AMD is determined for an individual and, in a second step, a medication comprising lutein and/or zeaxanthin and/or certain antioxidants (or a mixture thereof) is tailored to that individual. The invention also provides a method of determining a substance to be administered to an individual, which individual may be susceptible of having age-related macular degeneration (or an age-related macular degeneration-related disorder) comprising: a) determining the susceptibility of the individual to age-related macular degeneration (usually genetically, by detection of an SNP); and b) on the basis of the determination in a), identifying a substance capable of preventing or treating age-related macular degeneration in that individual. The method may additionally comprise providing (such as administering or communicating) the substance (or its identity) to the individual. | 06-18-2009 |
Regina Goralczyk, Grenzach-Whylen DE
Patent application number | Description | Published |
---|---|---|
20120142786 | OREGANO EXTRACT FOR ALERTNESS - extract can act as a stimulant, yet it does not interfere with sleep patterns or induce nervousness the way many stimulants such as caffeine can. It also has the benefits of promoting improved vigilance, improving attention and ability to focus on a task, and improving general alertness. | 06-07-2012 |
Regina Goralczyk, Basel CH
Patent application number | Description | Published |
---|---|---|
20130115182 | TOPICAL USE OF STEVIOL OR DERIVATIVES IN HAIR CARE - The present invention relates to the use of steviol and/or isosteviol, or a salt, ester, a diester, or an ether thereof as depicted in formula (I), formula (I): R1 wherein R1 is hydrogen (H) or a saturated, straight or branched C | 05-09-2013 |
20140044656 | NOVEL USE - The present invention relates to the use of steviol as well as derivatives thereof as a skin tanning agent. Furthermore, the present invention relates to the cosmetic topical application of steviol and derivatives thereof formulated into a composition comprising a cosmetically acceptable carrier for skin tanning. Finally, the invention relates to the use of steviol for enhancement of melanin formation in human skin cells. | 02-13-2014 |
20140050715 | PROTEIN HYDROLYSATES AS AGENTS FOR OVERCOMING ADDICTION - This invention is directed to the use of a protein hydrolysate, and in particular an egg lysozyme hydrolysate to assist an animal, including a human in overcoming an addition, or by breaking an unwanted habit. | 02-20-2014 |
20140129484 | METHOD OF MARKETING PROTEIN HYDROLYSATE FOR HIGH ENERGY SENSATION - Accordingly this invention relates to a method of increasing a feeling of energy in a healthy adult comprising administering a dosage form comprising a low dose of a Trp-containing di- and/or tri-peptide mixture characterized in that the peptide composition is an egg lysozyme hydrolysate with a Trp/LNAA ratio greater than 0.15 and which provides 30- to 50 mg Trp per dose. This dosage form should be administered multiple times per day for an extended period of time, such that the person receives 60-200 mg Trp per day. | 05-08-2014 |
Regina Goralczyk, Grenzach-Wyhien DE
Patent application number | Description | Published |
---|---|---|
20090270513 | 3,5-DIHYDROXY-2,4-CYCLOHEXADIENONES AND THEIR DERIVATIVES, DIETARY COMPOSITIONS AND FORTIFIED FOOD CONTAINING THEM AND THEIR USES - The present invention refers especially to 3,5-dihydroxy-2,4-cyclohexadienones of the general formula (I) wherein R | 10-29-2009 |
Regina Graul, Duxbury, MA US
Patent application number | Description | Published |
---|---|---|
20110150834 | CRTH2 MODULATORS - Modulators of CRTH2, particularly antagonists of CRTH2, that are useful for treating various disorders, including asthma and respiratory disorders are disclosed. The compounds fall within a genus described by formula I: | 06-23-2011 |
20110275683 | Selenophene and Selenazole Carboxylic Acid Derivatives - Derivatives of selenophene and selenazole heterocycles are disclosed. The compounds are useful as inhibitors of D-amino acid oxidase (DAO) and in the treatment of neurodegenerative and psychiatric diseases and disorders. | 11-10-2011 |
20110311483 | CRTH2 MODULATORS - Compounds of Formulae I-1 to I-9 are disclosed, which are modulators of CRTH2, particularly antagonists of CRTH2, that are useful for treating various disorders, including asthma and respiratory disorders. | 12-22-2011 |
20110312938 | Pyrrolopyridine Carboxylic Acid Derivatives - Disclosed are compounds and pharmaceutically acceptable salts of Formula (I) wherein R | 12-22-2011 |
20110312945 | CRTH2 MODULATORS - Modulators of CRTH2, particularly antagonists of CRTH2, that are useful for treating various disorders, including asthma and respiratory disorders are disclosed. The compounds fall within a genus described by formula I | 12-22-2011 |
20120149743 | Selenophene and Selenazole Carboxylic Acid Derivatives - Derivatives of selenophene and selenazole heterocycles are disclosed. The compounds are useful as inhibitors of D-amino acid oxidase (DAO) and in the treatment of neurodegenerative and psychiatric diseases and disorders. | 06-14-2012 |
20130216552 | CRTH2 MODULATORS - Modulators of CRTH2, particularly antagonists of CRTH2, that are useful for treating various disorders, including asthma and respiratory disorders are disclosed herein. The compounds are described by structural Formula I: | 08-22-2013 |
20130259830 | CRTH2 MODULATORS - Modulators of CRTH2, particularly antagonists of CRTH2, that are useful for treating various disorders, including asthma and respiratory disorders are disclosed. The compounds fall within a genus described by Formula I: | 10-03-2013 |
20140187795 | CRTH2 MODULATORS AND PREPARATION THEREOF - The present invention relates to processes and intermediates for the preparation of compounds useful as CRTH2 antagonists. Compounds prepared by the processes of the invention are of Formula (AI), (All) and Compound (I). | 07-03-2014 |
Regina Grillari, Bisamberg AT
Patent application number | Description | Published |
---|---|---|
20130045892 | PANELS OF IMMORTALIZED MAMMALIAN CELLS AND THEIR USE - Panels of mammalian cell samples, kits and methods of use thereof. The panels comprise samples or sets of samples of immortalized primary cells, obtained from different tissues and organs of healthy and/or diseased donors. The cell panels are useful in assays for testing effects of drug candidates, e.g. for activity and toxicity. | 02-21-2013 |
20130108687 | COMPOSITIONS FOR USE IN TREATING OR DIAGNOSING BONE DISORDERS AND/OR CARDIOVASCULAR DISORDERS | 05-02-2013 |
20130210883 | LIPASE INHIBITORS - The invention provides a compound of formula (I) as defined herein | 08-15-2013 |
20130323782 | METHOD OF GENERATING INDUCED PLURIPOTENT STEM CELLS AND DIFFERENTIATED CELLS - Methods for generating iPSCs and differentiated cells of interest by reprogramming donor cells that have been obtained in a non-invasive manner. In particular, the donor cells are exfoliated epithelial urine cells. The differentiated cells can be obtained by differentiation of the reprogrammed iPSCs or by direct reprogramming the urine cells. | 12-05-2013 |
20140162265 | COMPOSITIONS FOR USE IN TREATING OR DIAGNOSING BONE DISORDERS AND/OR CARDIOVASCULAR DISORDERS - The invention relates to methods for diagnosing bone disorders and/or cardiovascular disorders in a subject, by contacting a biological sample from the subject with (a) a nucleic acid molecule which hybridizes to miR-31 or its 5 or 3′ isoforms or variants, or (b) an agent that binds to miR-31 or its 5′ or 3′ isoforms or variants; detecting and evaluating the hybridization signal of the nucleic acid molecule or agent with a polynucleotide or said miR-31 or its 5′ or 3′ isoforms or variants; and comparing the detected and evaluated hybridization or binding signal with that of a control sample, wherein a stronger hybridization signal or a stronger binding signal in the sample of the subject compared to that of the control sample is indicative for a risk of developing or having a bone disorder and/or cardiovascular disorder | 06-12-2014 |
Regina Hoemme, Augsburg DE
Patent application number | Description | Published |
---|---|---|
20110070340 | Method for Controlling at Least Two Cooking Devices, Cooking Device, and System Including at Least Two Cooking Devices - The invention relates to a method for controlling at least two cooking devices, an associated cooking device and an associated system consisting of at least two cooking devices. According to the invention, data is generated in a control unit of at least one cooking device, said data being suitable for influencing the operation of another cooking device. The data is transmitted to a control unit ( | 03-24-2011 |
Regina Hofmann-Lehmann, Rapperswil CH
Patent application number | Description | Published |
---|---|---|
20080206778 | Feline Hemoplasma Isolate - A newly identified hemoplasma agent, Candidatus | 08-28-2008 |
20140141410 | FELINE LEUKEMIA VIRUS TRANS-MEMBRANE PROTEIN P15E FOR DIAGNOSIS OF FELV INFECTION - The invention provides for a method for the detection of FeLV infection in a patient, wherein a sample obtained from the patient is contacted in-vitro with a recombinant transmembrane p15E protein in a p15 (E) antibody binding step. | 05-22-2014 |
Regina Höh, Ludwigshafen DE
Patent application number | Description | Published |
---|---|---|
20110203649 | USE OF INDANTHRENE COMPOUNDS IN ORGANIC PHOTOVOLTAICS - The present invention relates to an organic solar cell which comprises at least one photoactive region which comprises at least one indanthrene compound which is in contact with at least one fullerene compound, and to the use of indanthrene compounds in organic photovoltaics, especially in the form of a component cell of a tandem cell. | 08-25-2011 |
Regina HÖh, Waldsee DE
Patent application number | Description | Published |
---|---|---|
20110308592 | USE OF SUBSTITUTED PERYLENES IN ORGANIC SOLAR CELLS - The present invention relates to an organic solar cell with a photoactive region which comprises at least one organic donor material in contact with at least one organic acceptor material, wherein the donor material and the acceptor material form a donor-acceptor heterojunction and wherein the photoactive region comprises at least one substituted perylene. | 12-22-2011 |
20120234380 | TERRYLENE COMPOUNDS, PREPARATION THEREOF AND USE THEREOF IN ORGANIC SOLAR CELLS - A terrylene compound of formula I: | 09-20-2012 |
Regina Huelgas, New York, NY US
Patent application number | Description | Published |
---|---|---|
20110318305 | SUBSTITUTED PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE IN TREATING VIRAL INFECTIONS - The present invention provides compounds of Formula (I): and tautomers, isomers, and esters of said compounds, and pharmaceutically acceptable salts, solvates, and prodrugs of said compounds, wherein each of R, R | 12-29-2011 |
Regina Illner, Nufringen DE
Patent application number | Description | Published |
---|---|---|
20090193263 | Identifying and processing an unauthorized access request - The system reuses the classic User ID & Password combination for authentication and adds a third component called a USE code for additional authorization check, as an example. This method allows access to a system when it is requested with correct User ID and Password (i.e., with correct pass code) but with an unauthorized USE code, the system identifies it as an unauthorized access and triggers the proper security measures to minimize the damage and monitor the actions in a way not to alarm the unauthorized user who is using the owner's credential to access the system. The USE Code is an extension to the pass code to raise various alarms and have a stepwise access level control based on different inputted values. | 07-30-2009 |
Regina Jeziórska, Warszawa PL
Patent application number | Description | Published |
---|---|---|
20120308666 | Method of Manufacturing the Silica Nanopowders with Biocidal Properties, Especially for Polymer Composites - Silica nanopowders with biocidal properties, especially for polymer composites, are produced by sol-gel method. The silica sol is produced from the aqueous mixture containing tetraalkoxysilane, in which alkoxy group contains from C | 12-06-2012 |
20130045282 | Method of Manufacturing the Silica Nanopowders With Fungicidal Properties, Especially for Polymer Composites - Method of manufacturing the silica nanopowders with fungicidal properties, consists in that the silica gel is obtained by sol-gel method from the reaction mixture containing tetraalkoxysilane and aliphatic alcohol, in the presence of ammonium compound, and thereafter the thermodegradable copper(II) salt a compound from the group of carbofunctional alkoxysilanes, and then, after evaporation of solvents the dry residue is heated at the decomposition temperature of copper(II) salt. | 02-21-2013 |
Regina Jeziórska, Warszawa PL
Patent application number | Description | Published |
---|---|---|
20120308666 | Method of Manufacturing the Silica Nanopowders with Biocidal Properties, Especially for Polymer Composites - Silica nanopowders with biocidal properties, especially for polymer composites, are produced by sol-gel method. The silica sol is produced from the aqueous mixture containing tetraalkoxysilane, in which alkoxy group contains from C | 12-06-2012 |
20130045282 | Method of Manufacturing the Silica Nanopowders With Fungicidal Properties, Especially for Polymer Composites - Method of manufacturing the silica nanopowders with fungicidal properties, consists in that the silica gel is obtained by sol-gel method from the reaction mixture containing tetraalkoxysilane and aliphatic alcohol, in the presence of ammonium compound, and thereafter the thermodegradable copper(II) salt a compound from the group of carbofunctional alkoxysilanes, and then, after evaporation of solvents the dry residue is heated at the decomposition temperature of copper(II) salt. | 02-21-2013 |
Regina Jokel, Toronto CA
Patent application number | Description | Published |
---|---|---|
20130297216 | METHOD AND SYSTEM OF LONGITUDINAL DETECTION OF DEMENTIA THROUGH LEXICAL AND SYNTACTIC CHANGES IN WRITING - The present invention is a method and system for detecting linguistic markers as signs and indicators of mental illness, even prior to onset of symptoms of the mental illness. The linguistic markers may be detected in diachronic analyses of writing or speech samples. In particular, the present invention may identify lexical and syntactic changes in language due to mental illness. To recognize such changes the present invention may utilize complete, fully parsed texts or speech representing a number of measures. The identification of markers may provide a means of detecting mental illness early on based on a person's use of language. The language may be presented as spontaneous speech or writing, and may include samples of speech and/or writing occurring over time. | 11-07-2013 |
Regina Kainzbauer, Worth An Der Donau DE
Patent application number | Description | Published |
---|---|---|
20100320460 | SYSTEM FOR SEPARATION OF AN ELECTRICALLY CONDUCTIVE CONNECTION - An integrated component includes a semiconductor substrate; at least one interconnect applied on the semiconductor substrate; an insulating layer applied on the at least one interconnect; and at least one opening through the insulating layer which interrupts the at least one interconnect into a first section and a second section. | 12-23-2010 |
Regina Kasprzykowska, Gdandski PL
Patent application number | Description | Published |
---|---|---|
20120108515 | NOVEL PEPTIDE DERIVATIVES FOR TREATMENT, PREVENTION OR ALLEVIATION OF A CONDITION ASSOCIATED WITH BONE LOSS OR LOW BONE DENSITY OR TO INHIBIT OSTEOCLAST DIFFERENTIATION AND STIMULATION - Novel compounds which may be for treatment, prevention or alleviation of a condition associated with bone loss or low bone density or to inhibit osteoclast differentiation and stimulation, bone resorption, or loosening of a prosthetic device. | 05-03-2012 |
20140243274 | NOVEL PEPTIDE DERIVATIVES FOR TREATMENT, PREVENTION OR ALLEVIATION OF A CONDITION ASSOCIATED WITH BONE LOSS OR LOW BONE DENSITY OR TO INHIBIT OSTEOCLAST DIFFERENTIATION AND STIMULATION - Compounds of formula R | 08-28-2014 |
Regina Kasprzykowska, Pruszcz Gdanski PL
Patent application number | Description | Published |
---|---|---|
20080255055 | Use of Derivatives of Dipeptides for the Manufacture of of a Medicament for the Treamtent of Microbial Infections - The invention relates to compositions comprising a compound based on the general formula (I) R | 10-16-2008 |
20090118198 | NOVEL PEPTIDE DERIVATIVES USEFUL AS ANTIMICROBIAL AGENTS FOR TREATING WOUNDS - The invention relates to a compound having the general formula (I) R | 05-07-2009 |
20100247648 | ANTIMICROBIAL COMPOUNDS - The invention relates to compositions comprising a compound based on the general formula (I) | 09-30-2010 |
Regina Kirchner-Gottschalk, Markgroeningen DE
Patent application number | Description | Published |
---|---|---|
20120283517 | Instrument handle for a medical diagnostic light, medical diagnostic light and medical diagnostic device - An instrument handle ( | 11-08-2012 |
Regina Klaeger, Landsberg DE
Patent application number | Description | Published |
---|---|---|
20100216872 | PLANT EXTRACT FROM LOW-THC CANNABIS FOR THE TREATMENT OF DISEASE - The present invention relates to a plant extract from a low-tetrahydrocannabinol (THC) variety of | 08-26-2010 |
20130012575 | PLANT EXTRACT FROM LOW-THC CANNABIS FOR THE TREATMENT OF DISEASE - The present invention relates to a plant extract from a low-tetrahydrocannabinol (THC) variety of | 01-10-2013 |
20150044315 | PLANT EXTRACT FROM LOW-THC CANNABIS FOR THE TREATMENT OF DISEASE - The present invention relates to a plant extract from a low-tetrahydrocannabinol (THC) variety of | 02-12-2015 |
Regina Klein, Speyer DE
Patent application number | Description | Published |
---|---|---|
20130157863 | MICROCAPSULE DISPERSION COMPRISING MICROCAPSULES WITH A HYDROPHILIC CAPSULE CORE - The present invention relates to microcapsule dispersions comprising microcapsules comprising a hydrophilic capsule core and a capsule wall polymer which is obtainable by polymerization of a monomer composition comprising | 06-20-2013 |
20140065197 | CARRIER SYSTEM FOR FRANGRANCES - The present invention relates to a carrier system for fragrances, to the production thereof and to the use of the carrier system in laundry and cosmetic formulations. Accordingly, the present invention is directed to a microcapsule comprising a core of hydrophobic material composed of at least one fragrance or perfume and a microcapsule shell obtainable by the suspension polymerization of the following monomers: | 03-06-2014 |
Regina Klein, Regensburg DE
Patent application number | Description | Published |
---|---|---|
20100137175 | NOVEL IONIC LIQUIDS - Novel ionic liquids comprising polyethercarboxylates as anions, a process for preparing them and their use. | 06-03-2010 |
Regina Kolesko, Emmendingen DE
Patent application number | Description | Published |
---|---|---|
20090308533 | FAST-CURING CHEMICAL FIXING SYSTEM AND USE THEREOF - Rapidly functional chemical fixing systems for anchoring elements, which fixing systems comprise a radically curing olefinic reactive resin formulation, a hardener and optionally additives, wherein the reactive resin formulation is composed of one or more curing olefinic reactive resins, one or more aminic accelerators, one or more non-phenolic (anaerobic) inhibitors and no or one or more phenolic inhibitors, and as the hardener there is provided a hardener with at least one peroxide as the initiator, wherein as the aminic accelerator(s) the reactive resin formulation comprises at least one highly active aminic accelerator in an amount of at least 1.5% by weight, based on the mass of the reactive resin formulation, the mass ratio of the accelerator to phenolic initiator is >5, and the reactive resin formulation comprises as non-phenolic inhibitor(s) up to 5% by weight of at least one non-phenolic inhibitor which has hardly any effect on the curing time, and in the hardener at least 1% of peroxide is provided. The very rapidly curing chemical fixing systems are especially suitable for fixing anchoring elements in the construction industry; these anchoring elements may become fixed a short time after the introduction of the chemical fixing system. | 12-17-2009 |
Regina Kreimer, Rishon Le Zion IL
Patent application number | Description | Published |
---|---|---|
20140067995 | Enterprise Workspaces Externalization - The present disclosure describes methods, systems, and computer program products for externalizing an enterprise workspace to business applications. One computer-implemented method includes indicating data within an application to be included in a new module, initiating a command to create the new module using the indicated data, transmitting the command to create the new module to an external server, receiving from the external server a list of available enterprise workspaces for adding the new module, selecting at least one available enterprise workspace from the list of available enterprise workspaces, transmitting the selected enterprise workspace to the external server, and receiving a confirmation of the new module creation. | 03-06-2014 |
Regina Kwiatkowski, Cambridge CA
Patent application number | Description | Published |
---|---|---|
20090033444 | CONFIGURABLE HIGH FREQUENCY COAXIAL SWITCH - Various embodiments are provided herein for a configurable high frequency coaxial switch. The switch includes a switch housing module that has at least two ports and is adapted for operation in a wide frequency band. The switch also includes at least one frequency-matching port component module that is configured to connect a transmission line to one of the ports of the switch housing module. The at least one frequency-matching port component module is also configured to provide a match to a desired frequency range. In use, the switch housing module together with the at least one frequency-matching port component module allow for operation of the configurable high frequency coaxial switch at the desired frequency range. | 02-05-2009 |
Regina Lischewski, Wolfen DE
Patent application number | Description | Published |
---|---|---|
20110136242 | Lanthanide Chelates and Use Thereof in Bioanalysis - Novel chemical compounds, with application in fluorometric analytical methods, for qualitative and quantitative determination of biomolecules. The aim of the invention is to identify and prove the suitability of such compounds. Said aim is achieved with compounds of formula (1) where R′ is an antenna function, R | 06-09-2011 |
Regina Lundigran, Duxbury, MA US
Patent application number | Description | Published |
---|---|---|
20090264653 | USEFUL INDOLE COMPOUNDS - Indoles that have activity as inhibitors of FAAH are described as are indoles and indole derivatives that have activity as inhibitors of DAO. | 10-22-2009 |
Regina Marbet, Ruetschelen CH
Patent application number | Description | Published |
---|---|---|
20140138410 | LIQUID DISPENSING SYSTEM - A manually energized dispensing system for dispensing a fluid ( | 05-22-2014 |
20140231549 | FLUID DISPENSING SYSTEM - A fluid dispensing system comprising a pump ( | 08-21-2014 |
Regina Martin, Jena DE
Patent application number | Description | Published |
---|---|---|
20090159816 | Method of testing optical materials by irradiating with high energy density radiation, optical materials selected by said method and uses thereof - An optical material for lithographic applications is selected from crystal materials by a testing method. The crystal materials are preferably quartz and/or alkali or alkaline earth halides, especially fluorides, or mixed crystals. The testing method includes three tests to measure irreversible radiation damage: 1) the optical material is irradiated with ultraviolet radiation at 193 nm and the non-intrinsic fluorescence intensity at 740 nm is measured; 2) the optical material is irradiated with high energy density laser light and a change in respective absorptions before and after irradiation at 385 nm is measured; and 3) the optical material is irradiated with an X-ray or radioactive source to form all possible color centers and a difference of respective surface integrals of corresponding absorption spectra in ultraviolet spectral and/or visible spectral regions is measured before and after irradiation. | 06-25-2009 |
20100001208 | METHOD FOR QUANTITATIVE DETERMINATION OF THE SUITABILITY OF CRYSTALS FOR OPTICAL COMPONENTS EXPOSED TO HIGH ENERGY DENSITIES, CRYSTALS GRADED IN THIS WAY AND USES THEREOF - A method is described for quantitative determination of suitability of an optical material, especially alkali halide and alkaline earth halide single crystals, for optical components exposed to high energy densities, especially of pulsed laser light at wavelengths under 250 nm. In this procedure radiation-dependent transmission of the optical material is determined at ultraviolet wavelengths by fluorescence measurements for fluorescence induced by ultraviolet radiation at these ultraviolet wavelengths. This is accomplished by a method including determining an induced fluorescence maximum of a non-linear absorption process, measuring a slope (|dT/dH|) of a functional relationship representing the dependence of the radiation-dependent transmission on fluence (H) for the induced fluorescence and determining radiation-dependent transmissions from this slope for particular fluence values. | 01-07-2010 |
Regina Meier, Ingolstadt DE
Patent application number | Description | Published |
---|---|---|
20140244131 | METHOD FOR OPERATING A DRIVER ASSISTANCE SYSTEM OF A MOTOR VEHICLE WITH A COMBINED LONGITUDINAL AND TRANSVERSE GUIDANCE FUNCTION - Method for operating a driver assistance system of a motor vehicle having a combined longitudinal and transverse guidance function, wherein, starting from the combined operation of the longitudinal and transverse guidance function, the longitudinal guidance function is disconnected in response to the presence of at least one determined first disconnection condition, whereas the transverse guidance function is maintained. | 08-28-2014 |
Regina Mendrzyk, Freiburg Im Breisgau DE
Patent application number | Description | Published |
---|---|---|
20120070461 | USE OF MYELOID CELL BIOMARKERS FOR THE DIAGNOSIS OF CANCER - The present invention relates to the use of myeloid cell biomarkers for the differential diagnosis, prognosis, and monitoring of renal cell carcinoma (RCC) or colorectal cancer (CRC). The present invention furthermore relates to monitoring the effect of a treatment against renal cell carcinoma (RCC) or colorectal cancer (CRC), and establishing a prognosis of the outcome of the treatment of renal cell carcinoma (RCC) or colorectal cancer (CRC). The present invention furthermore relates to panels of cellular biomarkers for use in the above methods, in particular multicolor panels for measuring said biomarkers. | 03-22-2012 |
Regina Miskewitz, Phoenix, AZ US
Patent application number | Description | Published |
---|---|---|
20090257963 | METHOD FOR MEASURABLY IMPROVING ORAL HEALTH - A composition for measurably improving oral health, a system including the composition, a method of using the composition and system, and a method of forming the composition and system are disclosed. The composition is a gel that maintains contact with a portion of an oral cavity for an extended period of time to, for example, prevent or reduce plaque and calculus buildup. The system includes a composition and a container encapsulating the composition. The composition is applied by rupturing the container and applying the composition through the ruptured portion of the container. In exemplary embodiments, the methods, systems and kits disclosed herein are suitable for measurably reducing an amount of gingivitis, periodontitis, bleeding, plaque and/or tartar. | 10-15-2009 |
20100035202 | SYSTEMS AND KITS FOR PROMOTING AND MAINTAINING ORAL HEALTH - Systems and kits dispensing material and methods of forming and using the systems and kits are disclosed. The system may include a deformable vessel portion for storing material and a spout portion for directing the material as the material is dispensed from the system. The vessel portion and the spout portion may be formed separately and subsequently coupled together to form the system. | 02-11-2010 |
Regina Mueller-Mach, San Jose, CA US
Patent application number | Description | Published |
---|---|---|
20080315228 | LOW PROFILE SIDE EMITTING LED WITH WINDOW LAYER AND PHOSPHOR LAYER - Low profile, side-emitting LEDs are described that generate white light, where all light is emitted within a relatively narrow angle generally parallel to the surface of the light-generating active layer. The LEDs enable the creation of very thin backlights for backlighting an LCD. In one embodiment, the LED emits blue light and is a flip chip with the n and p electrodes on the same side of the LED. Separately from the LED, a transparent wafer has deposited on it a red and green phosphor layer. The phosphor color temperature emission is tested, and the color temperatures vs. positions along the wafer are mapped. A reflector is formed over the transparent wafer. The transparent wafer is singulated, and the phosphor/window dice are matched with the blue LEDs to achieve a target white light color temperature. The phosphor/window is then affixed to the LED. | 12-25-2008 |
20110057205 | LED WITH PHOSPHOR TILE AND OVERMOLDED PHOSPHOR IN LENS - Overmolded lenses and certain fabrication techniques are described for LED structures. In one embodiment, thin YAG phosphor plates are formed and affixed over blue LEDs mounted on a submount wafer. A clear lens is then molded over each LED structure during a single molding process. The LEDs are then separated from the wafer. The molded lens may include red phosphor to generate a warmer white light. In another embodiment, the phosphor plates are first temporarily mounted on a backplate, and a lens containing a red phosphor is molded over the phosphor plates. The plates with overmolded lenses are removed from the backplate and affixed to the top of an energizing LED. A clear lens is then molded over each LED structure. The shape of the molded phosphor-loaded lenses may be designed to improve the color vs. angle uniformity. Multiple dies may be encapsulated by a single lens. In another embodiment, a prefabricated collimating lens is glued to the flat top of an overmolded lens. | 03-10-2011 |
20110084232 | ILLUMINATION SYSTEM COMPRISING A RADIATION SOURCE AND A FLUORESCENT MATERIAL - The invention concerns an illumination system for generation of colored, especially amber or red light, comprising a radiation source and a fluorescent material comprising at least one phosphor capable of absorbing a part of light emitted by the radiation source and emitting light of wavelength different from that of the absorbed light; wherein said at least one phosphor is a amber to red emitting a rare earth metal-activated oxonitridoalumosilicate of general formula (Ca | 04-14-2011 |
Regina Mullins-Schwaebler, Virginia Beach, VA US
Patent application number | Description | Published |
---|---|---|
20110085844 | Hand-held soap dispenser and washing device with flexible head - A soap dispenser and cleaning device includes a hollow soap reservoir having an end cap for refilling the reservoir with soap or other cleanser. A flexible neck is arranged at an end of the hollow soap reservoir opposite the end cap and includes a soap delivery channel arranged therein. A sponge holder head attaches to the flexible neck opposite the soap reservoir and includes at least one opening for delivering soap to a sponge attached thereto. The sponge is a resilient fluid communication sponge that delivers a cleanser to an item being washed. | 04-14-2011 |
Regina Neigel, Buehl DE
Patent application number | Description | Published |
---|---|---|
20090266815 | PRESSURE COMPENSATION ELEMENT, IN PARTICULAR FOR PRESSURE COMPENSATION IN A HOUSING - The invention relates to a pressure compensation device for compensating pressure between an inner chamber of a housing, in particular an electric motor, gearbox, container or the like and an outer side. The device includes a pressure compensation membrane mounted on an annular end face of a cylindrical structure that extends toward the outer side. The cylindrical structure is provided with a ventilation channel that extends therethrough. The cylindrical structure extends towards the outer side in order to form a projection from the wall of the housing, which projection is delimited by the end face on which the membrane is applied in a curved, dome-shaped form. A protective cover extends towards the outer side at a spaced apart distance in relation to the membrane over the cylindrical structure. | 10-29-2009 |
Regina Okner, Jerusalem IL
Patent application number | Description | Published |
---|---|---|
20090232867 | Modified conductive surfaces having active substances attached thereto - Novel processes for coating metal surfaces and/or for attaching active substances to metal surfaces, objects having coated metal surfaces and/or active substances attached thereto and uses thereof in the preparation of implantable devices are disclosed. | 09-17-2009 |
Regina Optehostert, Moers DE
Patent application number | Description | Published |
---|---|---|
20100209992 | Process for the production of a catalyst preparation and use of the catalyst preparation - A process is described for the production of a catalyst preparation, in which the catalyst containing at least one inorganic compound which is solid under standard conditions is comminuted by means of a dispersion unit into particles having a maximum average particle size d | 08-19-2010 |
20130172176 | Low-Alkali Catalyst Material and Process for Preparation Thereof - A catalyst material, more specifically a catalyst material based on TiO2/SiO2 in particulate form having a content of metal in the form of the metal oxide or metal oxide precursor, to processes for preparation thereof and to the use thereof in chemical catalysis, especially for removal of pollutants, such as nitrogen oxides from combustion gases | 07-04-2013 |
Regina Palkovits, Aachen DE
Patent application number | Description | Published |
---|---|---|
20120130071 | METHOD FOR OXIDIZING METHANE - Platinum(II) complexes and the use of these complexes for oxidation of methane to methyl sulfate are disclosed, the catalyst having, as ligands, a network based on aromatic N-heterocycles which has at least 2 coordinative nitrogen atoms per platinum atom, and the complex anion is selected from a halide, hydrogensulfate, hydrogensulfite, sulfate, sulfite, methylsulfate, methanol, water, hydroxide, carbon monoxide, hydrogencarbonate and carbonate. The catalyst enables a selective low-temperature oxidation of methane to methyl sulfate or methanol. The catalysts not only exhibit high activity, but can also be removed easily from the reaction mixture and reused over several runs without significant loss of activity. | 05-24-2012 |
Regina Palkovitz, Mülheim An Der Ruhr DE
Patent application number | Description | Published |
---|---|---|
20110015387 | METHOD FOR THE DEPOLYMERIZATION OF CELLULOSE - A process for the depolymerization of cellulose, in which a solution of cellulose in an ionic liquid is brought into contact with a solid acid as catalyst, is claimed. The cellulose can be depolymerized within a short reaction time to form a low molecular weight or oligomeric reaction mixture having a narrow molecular weight distribution (low polydispersity, d, defined as ratio of P | 01-20-2011 |
Regina Palkovitz, Mülheim An Der Ruhr DE
Patent application number | Description | Published |
---|---|---|
20110015387 | METHOD FOR THE DEPOLYMERIZATION OF CELLULOSE - A process for the depolymerization of cellulose, in which a solution of cellulose in an ionic liquid is brought into contact with a solid acid as catalyst, is claimed. The cellulose can be depolymerized within a short reaction time to form a low molecular weight or oligomeric reaction mixture having a narrow molecular weight distribution (low polydispersity, d, defined as ratio of P | 01-20-2011 |
Regina Pipits, Tartu EE
Patent application number | Description | Published |
---|---|---|
20130150262 | Method and Kit for Identifying Compounds Capable of Inhibiting Human Papilloma Virus Replication - This invention provides a method, kit and an in vitro system for identifying compounds capable of inhibiting Human Papilloma Virus replication at all the stages of viral replication cycle. The method, kit and in vitro system is applicable to all types of Human Papilloma Virus. The method enables high throughput screening of compounds inhibiting HPV replication in one or more phases of the cycle. | 06-13-2013 |
Regina Plail, Langenlois AT
Patent application number | Description | Published |
---|---|---|
20100196323 | Probiotic health or fitness promoting human or animal foodstuff and/or drinking water additive and use thereof - The invention relates to a probiotic health or fitness promoting human or animal foodstuff and/or drinking water additive, comprising a mixture of microorganisms, selected from the group | 08-05-2010 |
Regina Renhofa, Riga LV
Patent application number | Description | Published |
---|---|---|
20080292652 | Virus-Like Particles Comprising a Fusion Protein of the Coat Protein of Ap205 and an Antigenic Polypeptide - The present invention is in the fields of medicine, immunology, virology and molecular biology. The present invention provides a composition comprising a modified virus-like (VLP) particle derived from RNA bacteriophage AP205. The invention also provides a process for producing the aforementioned VLP. The modified VLP disclosed in the present invention is useful in the production of compositions for inducing immune responses for the prevention or treatment of diseases, disorders including infectious diseases, allergies, cancers and drug addiction. Moreover, the modified VLP disclosed in the present invention is, in particular, useful to efficiently induce self-specific immune responses, in particular antibody responses. | 11-27-2008 |
20100092508 | Molecular Antigen Arrays - The present invention provides a composition comprising an AP205 virus like particle (VLP) and an antigen. The invention also provides a process for producing an antigen or antigenic determinant bound to AP205 VLP. AP205 VLP bound to an antigen is useful in the production of compositions for inducing immune responses that are useful for the prevention or treatment of diseases, disorders or conditions including infectious diseases, allergies, cancer, drug addiction, poisoning and to efficiently induce self-specific immune responses, in particular antibody responses. | 04-15-2010 |
20100303846 | Immunostimulatory Nucleic Acid Packaged Particles for the Treatment of Hypersensitivity - The application is related to compositions and methods for the treatment of hypersensitivity, wherein the compositions comprise a particle packaged with immunostimulatory nucleic acids. The compositions of the invention are particularly useful in the treatment of atopic eczema, asthma and IgE-mediated allergy (type I allergy), especially pollen allergy and house dust allergy. | 12-02-2010 |
20120301499 | Packaging of Immunostimulatory Substances into Virus-Like Particles: Method of Preparation and Use - The invention relates to the finding that virus like particles (VLPs) can be loaded with immunostimulatory substances, in particular with DNA oligonucleotides containing non-methylated C and G (CpGs). Such CpG-VLPs are dramatically more immunogenic than their CpG-free counterparts and induce enhanced B and T cell responses. The immune response against antigens optionally coupled, fused or attached otherwise to the VLPs is similarly enhanced as the immune response against the VLP itself. In addition, the T cell responses against both the VLPs and antigens are especially directed to the Th1 type. Antigens attached to CpG-loaded VLPs may therefore be ideal vaccines for prophylactic or therapeutic vaccination against allergies, tumors and other self-molecules and chronic viral diseases. | 11-29-2012 |
20140056933 | IMMUNOSTIMULATORY NUCLEIC ACID PACKAGED PARTICLES FOR THE TREATMENT OF HYPERSENSITIVITY - The application is related to compositions and methods for the treatment of hypersensitivity, wherein the compositions comprise a particle packaged with immunostimulatory nucleic acids. The compositions of the invention are particularly useful in the treatment of atopic eczema, asthma and IgE-mediated allergy (type I allergy), especially pollen allergy and house dust allergy. | 02-27-2014 |
20150030620 | PACKAGING OF IMMUNOSTIMULATORY SUBSTANCES INTO VIRUS-LIKE PARTICLES: METHOD OF PREPARATION AND USE - The invention relates to the finding that virus like particles (VLPs) can be loaded with immunostimulatory substances, in particular with DNA oligonucleotides containing non-methylated C and G (CpGs). Such CpG-VLPs are dramatically more immunogenic than their CpG-free counterparts and induce enhanced B and T cell responses. The immune response against antigens optionally coupled, fused or attached otherwise to the VLPs is similarly enhanced as the immune response against the VLP itself. In addition, the T cell responses against both the VLPs and antigens are especially directed to the Th1 type. Antigens attached to CpG-loaded VLPs may therefore be ideal vaccines for prophylactic or therapeutic vaccination against allergies, tumors and other self-molecules and chronic viral diseases. | 01-29-2015 |
Regina Reszka, Panketal DE
Patent application number | Description | Published |
---|---|---|
20120122243 | MEANS AND METHOD AND MEANS FOR DIAGNOSING PROSTATE CARCINOMAS - The present invention relates to a method, preferably an ex vivo method, for diagnosing prostate carcinomas and/or predisposition thereof comprising determining at least one metabolite in a test sample of a subject suspected to suffer from prostate carcinomas or to have a predisposition therefor and comparing said at least one metabolite to a reference, whereby prostate carcinomas or a predisposition therefor is to be diagnosed. Moreover, the present invention encompasses a collection of metabolites, a data collection comprising characteristic values of metabolites and a storage medium comprising said data collection. Furthermore, the present invention also relates to a system comprising means for comparing characteristic values of metabolites of a sample operatively linked to a data storage medium. Further encompassed by the present invention are diagnostic means comprising at least one metabolite and the use of said at least one metabolite for the manufacture of diagnostic means for or for diagnosing prostate carcinomas. Finally, the present invention pertains to a method for identifying prostate carcinoma-related metabolites. | 05-17-2012 |
20120238028 | Means and Methods for Diagnosing Multiple Sclerosis - The present invention relates to the field of diagnostic methods. Specifically, the present invention contemplates a method for diagnosing multiple sclerosis in a subject, a method for identifying whether a subject is in need for a therapy of multiple sclerosis or a method for determining whether a multiple sclerosis therapy is successful. Moreover, contributed is a method for diagnosing or predicting the risk of an active status of multiple sclerosis in a subject. The invention also relates to tools for carrying out the aforementioned methods, such as diagnostic devices. | 09-20-2012 |
20120286157 | Means and Methods for Diagnosing Heart Failure in a Subject - The present invention relates to the field of diagnostic methods. Specifically, the present invention contemplates a method for diagnosing heart failure in a subject, a method for identifying whether a subject is in need for a therapy of heart failure or a method for determining whether a heart failure therapy is successful. The invention also relates to tools for carrying out the aforementioned methods, such as diagnostic devices. | 11-15-2012 |
20130140452 | MEANS AND METHODS FOR DIAGNOSING PANCREATIC CANCER IN A SUBJECT - The present invention relates to the field of diagnostic methods. Specifically, the present invention contemplates a method for diagnosing pancreatic cancer in a subject, a method for identifying whether a subject is in need for a therapy of pancreatic cancer or a method for determining whether a pancreatic cancer therapy is successful. The invention also relates to tools for carrying out the aforementioned methods, such as diagnostic devices. | 06-06-2013 |
20140323352 | Means and Methods for Diagnosing Pancreatic Cancer in a Subject - The present invention relates to the field of diagnostic methods. Specifically, the present invention contemplates a method for diagnosing pancreatic cancer in a subject, a method for identifying whether a subject is in need for a therapy of pancreatic cancer or a method for determining whether a pancreatic cancer therapy is successful. The invention also relates to tools for carrying out the aforementioned methods, such as diagnostic devices. | 10-30-2014 |
Regina Scholz, Berlin DE
Patent application number | Description | Published |
---|---|---|
20080268061 | Nanoparticle/Active Ingredient Conjugates - The present invention relates to nanoparticles, wherein at least one therapeutically active substance is bound to said nanoparticle and wherein the separation of the at least one therapeutically active substance from the nanoparticle is caused or initiated by an alternating magnetic filed. Furthermore, the present invention relates to pharmaceutical compositions, in particular to injection solutions containing the nanoparticles as well as to the use thereof for the treatment of cancer. | 10-30-2008 |
20120225128 | METHOD FOR CARRYING THERAPEUTIC SUBSTANCES INTO CELLS - The present invention relates to compositions containing nanoparticies and uses of said composition for transferring therapeutically active substances into cells by means of specifically coated nanoparticles. The chemical design of the particles is such that a large amount thereof is absorbed into the cells. No direct bond between nanoparticle and the therapeutically active substance is required for the transfer into the cells. Thanks to said transfer, an increased efficacy of the substance and simultaneously reduced systemic toxicity is achieved, i.e. an increase in the efficacy while the side effects are reduced. | 09-06-2012 |
Regina Schwering, Euskirchen DE
Patent application number | Description | Published |
---|---|---|
20110174192 | SUGAR MICRO/NANOFOAMS - A method for producing rigid sugar micro-/nanofoams includes providing a solution with at least one sugar, a super- or near-critical fluid and a surfactant component as a (micro)emulsion. The (micro)emulsion is expanded so as to convert the super- or near-critical fluid from a state of liquid-like density to a state of gaseous density so as to thereby obtain a micro-/nanofoam. The micro-/nanofoam is then rigidified so as to obtain a rigid sugar micro-/nanofoam. | 07-21-2011 |
Regina Soufli, Berkeley, CA US
Patent application number | Description | Published |
---|---|---|
20130100976 | CORROSION-RESISTANT MULTILAYER STRUCTURES WITH IMPROVED REFLECTIVITY - In one general embodiment, a thin film structure includes a substrate; a first corrosion barrier layer above the substrate; a reflective layer above the first corrosion barrier layer, wherein the reflective layer comprises at least one repeating set of sub-layers, wherein one of the sub-layers of each set of sub-layers being of a corrodible material; and a second corrosion barrier layer above the reflective layer. In another general embodiment, a system includes an optical element having a thin film structure as recited above; and an image capture or spectrometer device. In a further general embodiment, a laser according to one embodiment includes a light source and the thin film structure as recited above. | 04-25-2013 |
Regina Spennacchio, Jupiter, FL US
Patent application number | Description | Published |
---|---|---|
20140175094 | First-In First-Out Storage Container - A storage container used to provide first-in, first-out storage of consumable products stored in individual packages, which utilizes a bottom panel, front panel, rear panel, side panels, a base, and a slot, to allow the user to efficiently and reliably remove the first-stored individual package through the slot located on the front panel of the storage container near its base. In addition, a pull tab and handles are made part of the storage container to allow for ease in transport of the storage container. Further, single bands of material are wrapped around the perimeter of the storage container to provide additional support to the storage container. Optionally, a lid is used to cover the open top of the storage container. Additionally, the base can be removed from the storage container such that the storage container will be collapsible. | 06-26-2014 |
Regina Spiehl, Norcross, GA US
Patent application number | Description | Published |
---|---|---|
20080208107 | TRANSDERMAL PORATOR AND PATCH SYSTEM AND METHOD FOR USING SAME - A transdermal permeant delivery system for delivery of at least one permeant composition into a tissue membrane of a subject including a disposable substrate having at least a portion of a bottom surface of a first release liner connected to an upper surface of the substrate and a patch having a backing layer and a reservoir that is selectively removable from the top surface of the first release liner. In a connected position, a first portion of the backing layer of the patch is releaseably mounted to a top surface of the first release liner in spaced registration with a poration area of the substrate. | 08-28-2008 |
20120035555 | TRANSDERMAL PORATOR AND PATCH SYSTEM AND METHOD FOR USING SAME - A transdermal permeant delivery system for delivery of at least one permeant composition into a tissue membrane of a subject including a disposable substrate having at least a portion of a bottom surface of a first release liner connected to an upper surface of the substrate and a patch having a backing layer and a reservoir that is selectively removable from the top surface of the first release liner. In a connected position, a first portion of the backing layer of the patch is releaseably mounted to a top surface of the first release liner in spaced registration with a poration area of the substrate. | 02-09-2012 |
Regina Stoltenburg, Leipzig DE
Patent application number | Description | Published |
---|---|---|
20140141446 | Aptamers That Are Specific for Immunoglobulin-Binding Cell Wall Proteins - The invention relates to an aptamer that binds to protein A, G or L, protein A-, G- or L-containing substances, and also to protein A-, G- or L-containing microorganisms, in particular | 05-22-2014 |
Regina Valluzzi, Medford, MA US
Patent application number | Description | Published |
---|---|---|
20080314835 | Chiral separating agents with active support - A chiral stationary phase for use in chromatographic separation comprising a chiral selector compound and a chiral support material, wherein the chiral support material comprises a polymer comprising at least 30% chiral monomer of the same orientation. | 12-25-2008 |
20100230339 | Particulate chiral separation material - A chiral particulate material and method of making the same are provided. The material includes a fibrous protein or chiral synthetic polymer, optionally crosslinked, organized into a multilayered chiral structure including nanoscale chiral pores or channels. The particles are useful for performing chiral separations, including in chromatographic applications. | 09-16-2010 |
20100294716 | Templated Native Silk Smectic Gels - One aspect of the present invention relates to a method of preparing a fibrous protein smectic hydrogel by way of a solvent templating process, comprising the steps of pouring an aqueous fibrous protein solution into a container comprising a solvent that is not miscible with water; sealing the container and allowing it to age at about room temperature; and collecting the resulting fibrous protein smectic hydrogel and allowing it to dry. Another aspect of the present invention relates to a method of obtaining predominantly one enantiomer from a racemic mixture, comprising the steps of pouring an aqueous fibrous protein solution into a container comprising a solvent that is not miscible with water; sealing the container and allowing it to age at about room temperature; allowing the enantiomers of racemic mixture to diffuse selectively into the smectic hydrogel in solution; removing the smectic hydrogel from the solution; rinsing predominantly one enantiomer from the surface of the smectic hydrogel; and extracting predominantly one enantiomer from the interior of the smectic hydrogel. The present invention also relates to a smectic hydrogel prepared according to an aforementioned method. | 11-25-2010 |
Regina Valluzzi, Arlington, MA US
Patent application number | Description | Published |
---|---|---|
20140155496 | Templated Native Silk Smectic Gels - One aspect of the present invention relates to a method of preparing a fibrous protein smectic hydrogel by way of a solvent templating process, comprising the steps of pouring an aqueous fibrous protein solution into a container comprising a solvent that is not miscible with water; sealing the container and allowing it to age at about room temperature; and collecting the resulting fibrous protein smectic hydrogel and allowing it to dry. Another aspect of the present invention relates to a method of obtaining predominantly one enantiomer from a racemic mixture, comprising the steps of pouring an aqueous fibrous protein solution into a container comprising a solvent that is not miscible with water; sealing the container and allowing it to age at about room temperature; allowing the enantiomers of racemic mixture to diffuse selectively into the smectic hydrogel in solution; removing the smectic hydrogel from the solution; rinsing predominantly one enantiomer from the surface of the smectic hydrogel; and extracting predominantly one enantiomer from the interior of the smectic hydrogel. The present invention also relates to a smectic hydrogel prepared according to an aforementioned method. | 06-05-2014 |
Regina Voegeli-Lange, Basel CH
Patent application number | Description | Published |
---|---|---|
20100280053 | CyclopropylmethYl-[7-(5,7-dimethyl-benzo[1,2,5]thiodiazol-4-yl)-2,5,6-trim- ethyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-4-propyl-amine as a CRF Antagonist - The present invention relates to a novel benzothiadiazole of formula (A) in free base or acid addition salt form, its preparation, its use as pharmaceutical and pharmaceutical compositions containing the compound. | 11-04-2010 |
Regina Wendenburg, Berlin DE
Patent application number | Description | Published |
---|---|---|
20100011461 | Nucleic acid molecules encoding enzymes having fructosyltransferase activity, and their use - Nucleic acid molecules are described which encode polypeptides having the enzymatic activity of a fructosyltransferase. Also, vectors, host cells and transgenic plants are described which contain such nucleic acid molecules. Furthermore, processes for producing polyfructose, particularly that of the inulin type, using the hosts described and/or the fructosyltransferase produced by them are described. | 01-14-2010 |
Regina Whitemarsh, Madison, WI US
Patent application number | Description | Published |
---|---|---|
20140080142 | Compositions and Methods of Using Differentiated Cells Sensitized to Botulinum Neurotoxin - Differentiated cholinergic cells having motor neuron-like morphology and increased sensitivity to botulinum neurotoxin are provided herein. Methods of using such differentiated cells for detecting neurotoxin are also provided. | 03-20-2014 |
Regina Widdows, Ivyland, PA US
Patent application number | Description | Published |
---|---|---|
20130218583 | Electronic Patient Monitoring System and Method - An electronic patient monitoring system that includes a not easily removable patient identification and monitoring device, an observer transmitter/receiver device to communicate with the not easily removable patient identification and monitoring device when within a specified visual range of each other within a predefined time interval, and a central computer system including, at least, a computer processor, communications components and system software to communicate with the observer transmitter/receiver device at specified/predetermined time intervals to receive observer- and patient-specific information. | 08-22-2013 |
Regina Wilpiszeski, Cambridge, MA US
Patent application number | Description | Published |
---|---|---|
20110111470 | Methods and Compositions for the Recombinant Biosynthesis of Fatty Acids and Esters - The present disclosure identifies methods and compositions for modifying photoautotrophic organisms, such that the organisms efficiently convert carbon dioxide and light into compounds such as esters and fatty acids. In certain embodiments, the compounds produced are secreted into the medium used to culture the organisms. | 05-12-2011 |
20120009636 | Methods and Compositions for the Recombinant Biosynthesis of Fatty Acids and Esters - The present disclosure identifies methods and compositions for modifying photoautotrophic organisms, such that the organisms efficiently convert carbon dioxide and light into compounds such as esters and fatty acids. In certain embodiments, the compounds produced are secreted into the medium used to culture the organisms. | 01-12-2012 |
20130143306 | Methods and Compositions for the Recombinant Biosynthesis of Fatty Acids and Esters - The present disclosure identifies methods and compositions for modifying photoautotrophic organisms, such that the organisms efficiently convert carbon dioxide and light into compounds such as esters and fatty acids. In certain embodiments, the compounds produced are secreted into the medium used to culture the organisms. | 06-06-2013 |
20150082691 | Methods and Compositions for the Recombinant Biosynthesis of Fatty Acids and Esters - The present disclosure identifies methods and compositions for modifying photoautotrophic organisms, such that the organisms efficiently convert carbon dioxide and light into compounds such as esters and fatty acids. In certain embodiments, the compounds produced are secreted into the medium used to culture the organisms. | 03-26-2015 |